A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Additional Benefit of a Multistrain Synbiotic (Prodefen®) in the Clinical Management of Acute Viral Diarrhea in Children

This randomized, open-label study evaluated the additional benefits of the synbiotic Prodefen® in the clinical management of acute diarrhea of suspected viral origin in children between 6 months and 12 years of age. Study outcomes included the duration of diarrhea, the recovery from diarrhea, and th...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Menor, Emilia, García-Marín, Fátima, Vecino-López, Raquel, Horcajo-Martínez, Gloria, de Ibarrondo Guerrica-Echevarría, María-José, Gómez-González, Pedro, Velasco-Ortega, Syra, Suárez-Almarza, Javier, Nieto-Magro, Concepción
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308530/
https://www.ncbi.nlm.nih.gov/pubmed/28229091
http://dx.doi.org/10.1177/2333794X16679587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308530/
https://www.ncbi.nlm.nih.gov/pubmed/28229091
http://dx.doi.org/10.1177/2333794X16679587

Ejemplares similares